Status:
UNKNOWN
N-GAL Allows Intensive Treatment of Contrast Induced Nephropathy
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Patients who undergo urgent/emergency coronary angiography can not receive any preventive treatment of contrast induced nephropathy. We tested the hypothesis that Neutrophil gelatinase-associated lipo...
Detailed Description
Background Patients who undergo urgent/emergency coronary angiography can not receive any preventive treatment of contrast induced nephropathy. An acute kidney injury is generally detected too late t...
Eligibility Criteria
Inclusion
- Indication to urgent/emergency coronary angiography
- Normal renal function (eGFR\> 60 ml/min/1.73 m2)
- Moderate or high Mehran's risk score for CIN (\>11).
- Able to understand and willing to sign the informed consent form
Exclusion
- • Women of child bearing potential patients must demonstrate a negative pregnancy test performed within 24 hours before
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01491243
Start Date
January 1 2014
End Date
December 1 2017
Last Update
March 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University La Sapienza
Rome, Italy, 00166